California biotech startup OrsoBio is betting the future of obesity drugs lies in combination approaches.
To get there, OrsoBio told Endpoints News that it raised …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A committee established last July by Japan’s Ministry of Health, Labour and Welfare has been reviewing pharmaceutical regulations in Japan, looking at revisions to the
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
A breakthrough study, published in Science Translational Medicine, features a biomedical engineering innovation with the potential to transform trauma care and surgical practices.